GB201510493D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB201510493D0
GB201510493D0 GBGB1510493.8A GB201510493A GB201510493D0 GB 201510493 D0 GB201510493 D0 GB 201510493D0 GB 201510493 A GB201510493 A GB 201510493A GB 201510493 D0 GB201510493 D0 GB 201510493D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1510493.8A
Other versions
GB2548542A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Redx Pharna PLC
Original Assignee
Redx Pharna PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redx Pharna PLC filed Critical Redx Pharna PLC
Priority to GB1510493.8A priority Critical patent/GB2548542A/en
Publication of GB201510493D0 publication Critical patent/GB201510493D0/en
Publication of GB2548542A publication Critical patent/GB2548542A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
GB1510493.8A 2015-06-16 2015-06-16 Compounds Withdrawn GB2548542A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1510493.8A GB2548542A (en) 2015-06-16 2015-06-16 Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1510493.8A GB2548542A (en) 2015-06-16 2015-06-16 Compounds

Publications (2)

Publication Number Publication Date
GB201510493D0 true GB201510493D0 (en) 2015-07-29
GB2548542A GB2548542A (en) 2017-09-27

Family

ID=53784763

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1510493.8A Withdrawn GB2548542A (en) 2015-06-16 2015-06-16 Compounds

Country Status (1)

Country Link
GB (1) GB2548542A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114573510A (en) * 2015-12-16 2022-06-03 洛克索肿瘤学股份有限公司 Compounds useful as kinase inhibitors

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108424414A (en) * 2017-12-08 2018-08-21 苏州国匡医药科技有限公司 Indoleamine 2,3-dioxygenase modulating compound of the one kind containing heterocycle and its purposes in pharmacy
CN108467365B (en) * 2018-03-12 2021-05-04 郑州工程技术学院 IDO enzyme inhibitor compound and preparation method and application thereof
US11351149B2 (en) 2020-09-03 2022-06-07 Pfizer Inc. Nitrile-containing antiviral compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2694640T3 (en) * 2011-04-15 2018-03-17
RU2667509C2 (en) * 2013-03-14 2018-09-21 Ньюлинк Джинетикс Корпорейшин Tricyclic compounds as inhibitors of immunosuppression mediated by tryptophan metabolization
CN105037371A (en) * 2015-06-30 2015-11-11 西华大学 Deuterated indoleamine-2,3-dioxygenase inhibitor

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114573510A (en) * 2015-12-16 2022-06-03 洛克索肿瘤学股份有限公司 Compounds useful as kinase inhibitors
CN114591242A (en) * 2015-12-16 2022-06-07 洛克索肿瘤学股份有限公司 Compounds useful as kinase inhibitors
CN114634447A (en) * 2015-12-16 2022-06-17 洛克索肿瘤学股份有限公司 Compounds useful as kinase inhibitors

Also Published As

Publication number Publication date
GB2548542A (en) 2017-09-27

Similar Documents

Publication Publication Date Title
GB201510019D0 (en) Compounds
GB201514754D0 (en) Compounds
GB201514751D0 (en) Compounds
PL3362444T3 (en) Compounds
GB201508747D0 (en) Compounds
GB201520500D0 (en) Compounds
GB201520499D0 (en) Compounds
GB201508864D0 (en) Compounds
IL253813A0 (en) Diaza-benzofluoranthrene compounds
GB201510493D0 (en) Compounds
PT3331885T (en) Compounds
GB201521682D0 (en) Compounds
GB201520419D0 (en) Compounds
GB201508857D0 (en) Compounds
GB201503926D0 (en) Compounds
GB201501115D0 (en) Compounds
GB201522246D0 (en) Compounds
GB201521912D0 (en) Compounds
GB201521440D0 (en) Compounds
GB201521086D0 (en) Compounds
GB201519969D0 (en) Compounds
GB201519965D0 (en) Compounds
GB201519549D0 (en) Compounds
GB201519213D0 (en) Compounds
GB201519212D0 (en) Compounds

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)